Thrombotic Antiphospholipid Syndrome Shows Strong Haplotypic Association with SH2B3-ATXN2 Locus

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Ochoa, Eguzkine ^a   Iriondo, Mikel ^a   Bielsa, Ana ^a   Ruiz Irastorza, Guillermo ^a   Estonba, Andone ^a   Zubiaga, Ana M ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ATXN2 GENE; COHORT ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; SH2B3 GENE; THROMBOPHILIA; THROMBOTIC ANTIPHOSPHOLIPID SYNDROME;

ADULT; ALLELES; ANTIPHOSPHOLIPID SYNDROME; CHROMOSOME MAPPING; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; GENE ORDER; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS;

EID: 84879750568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067897     Document Type: Article

References (54)

1. Meroni PL, Borghi MO, Raschi E, Tedesco F, (2011) Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 7: 330-339.
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306.
3. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA, (2010) Antiphospholipid syndrome. Lancet 376: 1498-1509.
4. Zhou H, Wolberg AS, Roubey RA, (2004) Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 104: 2353-2358.
5. Vega-Ostertag ME, Pierangeli SS, (2007) Mechanisms of aPL-mediated thrombosis: effects of aPL on endothelium and platelets. Curr Rheumatol Rep 9: 190-197.
6. Potti A, Bild A, Dressman HK, Lewis DA, Nevins JR, et al. (2006) Gene-expression patterns predict phenotypes of immune-mediated thrombosis. Blood 107: 1391-1396.
7. Hamid C, Norgate K, D'Cruz DP, Khamashta MA, Arno M, et al. (2007) Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome. Ann Rheum Dis 66: 1000-1007.
8. Bernales I, Fullaondo A, Marin-Vidalled MJ, Ucar E, Martinez-Taboada V, et al. (2008) Innate immune response gene expression profiles characterize primary antiphospholipid syndrome. Genes Immun 9: 38-46.
9. Lopez-Pedrera C, Cuadrado MJ, Herandez V, Buendia P, Aguirre MA, et al. (2008) Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis. Arthritis Rheum 58: 2835-2844.
10. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, et al. (2000) Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 31: 1283-1288.
11. Galli M, Finazzi G, Duca F, Norbis F, Moia M, (2000) The G1691-> A mutation of factor V, but not the G20210-> A mutation of factor II or the C677-> T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants. Br J Haematol 108: 865-870.
12. Pierangeli SS, Vega-Ostertag ME, Raschi E, Liu X, Romay-Penabad Z, et al. (2007) Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis 66: 1327-1333.
13. de la Red G, Tassies D, Espinosa G, Monteagudo J, Bove A, et al. (2009) Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels. Thromb Haemost 101: 312-316.
14. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747-753.
15. Pielberg G, Day AE, Plastow GS, Andersson L, (2003) A sensitive method for detecting variation in copy numbers of duplicated genes. Genome Res 13: 2171-2177.
16. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, et al. (2006) Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439: 851-855.
17. Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, et al. (2007) FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39: 721-723.
18. Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, et al. (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464: 713-720.
19. Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, et al. (2011) Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus 20: 206-218.
20. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al. (2006) Global variation in copy number in the human genome. Nature 444: 444-454.
21. Consortium WTCC, (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
22. McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, et al. (2006) Common deletion polymorphisms in the human genome. Nat Genet 38: 86-92.
23. Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK, (2006) A high-resolution survey of deletion polymorphism in the human genome. Nat Genet 38: 75-81.
24. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
25. Lipson D, Aumann Y, Ben-Dor A, Linial N, Yakhini Z, (2006) Efficient calculation of interval scores for DNA copy number data analysis. J Comput Biol 13: 215-228.
26. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
27. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
28. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, et al. (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41: 703-707.
29. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228-1233.
30. Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, et al. (2009) Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41: 342-347.
31. Ikram MK, Sim X, Jensen RA, Cotch MF, Hewitt AW, et al. (2010) Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet 6: e1001184.
32. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, et al. (2009) Genome-wide association study of blood pressure and hypertension. Nat Genet 41: 677-687.
33. Matarin M, Brown WM, Scholz S, Simon-Sanchez J, Fung HC, et al. (2007) A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol 6: 414-420.
34. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, et al. (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41: 666-676.
35. Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, et al. (2011) Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 7: e1002216.
36. Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333-338.
37. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, et al. (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42: 508-514.
38. Wain LV, Verwoert GC, O'Reilly PF, Shi G, Johnson T, et al. (2011) Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet 43: 1005-1011.
39. Wild PS, Zeller T, Schillert A, Szymczak S, Sinning CR, et al. (2011) A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet 4: 403-412.
40. Zhernakova A, Stahl EA, Trynka G, Raychaudhuri S, Festen EA, et al. (2011) Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 7: e1002004.
41. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, et al. (2010) Origins and functional impact of copy number variation in the human genome. Nature 464: 704-712.
42. Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, et al. (2010) New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376-384.
43. Velazquez L, Cheng AM, Fleming HE, Furlonger C, Vesely S, et al. (2002) Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med 195: 1599-1611.
44. Devalliere J, Charreau B, (2011) The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem Pharmacol 82: 1391-1402.
45. Fitau J, Boulday G, Coulon F, Quillard T, Charreau B, (2006) The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and-2 pathways. J Biol Chem 281: 20148-20159.
46. Li Y, He X, Schembri-King J, Jakes S, Hayashi J, (2000) Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J Immunol 164: 5199-5206.
47. Takaki S, Morita H, Tezuka Y, Takatsu K, (2002) Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J Exp Med 195: 151-160.
48. Lavrikova EY, Nikitin AG, Kuraeva TL, Peterkova VA, Tsitlidze NM, et al. (2011) The carriage of the type 1 diabetes-associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients. Pediatr Diabetes 12: 127-132.
49. Alcina A, Vandenbroeck K, Otaegui D, Saiz A, Gonzalez JR, et al. (2010) The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun 11: 439-445.
50. Zhernakova A, Elbers CC, Ferwerda B, Romanos J, Trynka G, et al. (2010) Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet 86: 970-977.
51. Sivapalaratnam S, Farrugia R, Nieuwdorp M, Langford CF, van Beem RT, et al. (2011) Identification of candidate genes linking systemic inflammation to atherosclerosis; results of a human in vivo LPS infusion study. BMC Med Genomics 4: 64.
52. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, et al. (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 42: 295-302.
53. Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, et al. (2008) Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 40: 395-402.
54. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, et al. (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39: 857-864.